Filed before 2025Filed 15 June 2022
Artizan Biosciences, Inc. has sold $18.9M so far
Artizan Biosciences, Inc., a biotech company based in New Haven, CT, has sold $18.9M so far in its equity round, according to a filing dated 15 June 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 15 June 2022
- First filed
- 23 December 2020
- Round
- Equity round (amended filing)
- Amount sold
- $18.9M
- Offering size
- $18.9M
- Investors so far
- 7
- Based in
- New Haven, CT
- Website
- piprtx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 68% of the 1,764 tracked raises with an amount filed in 2022, and than 66% of the 142 in biotech.
PIPr Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 12 Nov 2025 | New filing | $1.5M | Another raise |
| 15 Jun 2022 | Amended filing | $18.9M | This raise |
| 23 Dec 2020 | New filing | $10.9M | This raise |
| 4 Mar 2020 | New filing | $1.74M | Another raise |
| 8 Mar 2019 | New filing | $5M | Another raise |
More with Hatteras on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.